Coherus BioSciences, Inc. 4
4 · Coherus BioSciences, Inc. · Filed Jul 13, 2016
Insider Transaction Report
Form 4
Watler Peter K.
Chief Technical Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2016-07-11−43,495→ 0 total(indirect: By Spouse)Exercise: $2.08Exp: 2023-02-27→ Common Stock (43,495 underlying) - Sale
Common Stock, $0.0001 par value
2016-07-11$20.02/sh−43,495$870,931→ 0 total(indirect: By Spouse) - Exercise/Conversion
Common Stock, $0.0001 par value
2016-07-11$2.08/sh+43,495$90,635→ 43,495 total(indirect: By Spouse)
Footnotes (3)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person's wife.
- [F2]The transaction was executed in multiple trades in prices ranging from $20.00 to $20.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from June 4, 2012, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.